![Athanasios Tsiatis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Athanasios Tsiatis
Directeur Technique/Scientifique/R&D chez
ALX ONCOLOGY HOLDINGS INC.
Profil
Athanasios Tsiatis currently works at ALX Oncology Holdings, Inc., as Senior Vice President-Clinical Development from 2021.
Dr. Tsiatis also formerly worked at Plexxikon, Inc., as Vice President-Clinical Development from 2020 to 2021.
Dr. Tsiatis received his undergraduate degree from New York University and doctorate degree from Vanderbilt University School of Medicine.
Postes actifs de Athanasios Tsiatis
| Sociétés | Poste | Début |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Directeur Technique/Scientifique/R&D | 01/11/2021 |
Anciens postes connus de Athanasios Tsiatis
| Sociétés | Poste | Fin |
|---|---|---|
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Directeur Technique/Scientifique/R&D | 01/11/2021 |
Formation de Athanasios Tsiatis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Commercial Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University School of Medicine
 Vanderbilt University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
